U-Blot® Research Grade TefibazumabCat. No. WA3628Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade TefibazumabCat. No. WA3628
U-Blot® Research Grade TecotabartCat. No. WA3627
U-Blot® Research Grade Tecnemab-K-1Cat. No. WA3626
U-Blot® Research Grade TeclistamabCat. No. WA3625
U-Blot® Research Grade TecaginlimabCat. No. WA3624
U-Blot® Research Grade TebotelimabCat. No. WA3623
U-Blot® Research Grade TebentafuspCat. No. WA3622
U-Blot® Research Grade TazlestobartCat. No. WA3621
U-Blot® Research Grade TavolimabCat. No. WA3620
U-Blot® Research Grade TarumaseCat. No. WA3619
U-Blot® Research Grade TarperprumigCat. No. WA3618
U-Blot® Research Grade TarlatamabCat. No. WA3617